RxDoctor Payments Data

Elizabeth Spiers, MD

Dermatopathology · Doylestown, PANPI 1861470171

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $58,288 of the $65,124 with a category attached, or 89.5%. Galderma Laboratories, L.p. accounts for 98.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $29,228 and has fallen 89.4% since, to $3,088 in 2025. Among dermatopathology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,124in general payments, 2019–2025

Across 133 payments — averaging $489.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$64K
  • Regeneron Healthcare Solutions, Inc.$425
  • Johnson & Johnson$193
  • Lilly USA, LLC$136
  • Hologic Sales And Service, LLC$130
  • LEO Pharma Inc.$43
  • plus $79 from 5 others

What the payments were for

  • Speaking & faculty fees$58,28890%
  • Travel & lodging$3,8236%
  • Food & beverage$2,9094%
  • Education$1050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,124 in reported general payments places this provider in the 95th percentile of 27 dermatopathology providers in Pennsylvania.

See all dermatopathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$422,535
Medicare patients
1,569
Services billed
5,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept13$90,310
Metronidazole54$4,070
Tacrolimus30$2,943
Fluorouracil59$2,852
Clobetasol Propionate83$1,636
Fluocinonide75$1,403
ValacyclovirValacyclovir Hcl51$1,173
Desonide59$1,006
Triamcinolone Acetonide136$916
Doxycycline Hyclate61$886
Ketoconazole39$839
Mupirocin43$245

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →